These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 28271325
1. Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy. Mondal S, Rangasamy SB, Ghosh S, Watson RL, Pahan K. Neurochem Res; 2017 May; 42(5):1555-1570. PubMed ID: 28271325 [Abstract] [Full Text] [Related]
2. Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline. Mondal S, Martinson JA, Ghosh S, Watson R, Pahan K. PLoS One; 2012 May; 7(12):e51869. PubMed ID: 23284794 [Abstract] [Full Text] [Related]
3. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. Mondal S, Pahan K. PLoS One; 2015 May; 10(1):e0116566. PubMed ID: 25569428 [Abstract] [Full Text] [Related]
4. Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair. Rao VT, Khan D, Jones RG, Nakamura DS, Kennedy TE, Cui QL, Rone MB, Healy LM, Watson R, Ghosh S, Antel JP. Sci Rep; 2016 Jul 25; 6():30020. PubMed ID: 27451946 [Abstract] [Full Text] [Related]
5. Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis. Jana M, Ghosh S, Pahan K. Neurochem Res; 2018 Feb 25; 43(2):407-419. PubMed ID: 29143164 [Abstract] [Full Text] [Related]
6. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. Dasgupta S, Zhou Y, Jana M, Banik NL, Pahan K. J Immunol; 2003 Apr 01; 170(7):3874-82. PubMed ID: 12646656 [Abstract] [Full Text] [Related]
7. Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. Brahmachari S, Pahan K. J Immunol; 2007 Jul 01; 179(1):275-83. PubMed ID: 17579047 [Abstract] [Full Text] [Related]
8. Glyceryl Tribenzoate: A Flavoring Ingredient, Inhibits the Adoptive Transfer of Experimental Allergic Encephalomyelitis via TGF-β: Implications for Multiple Sclerosis Therapy. Mondal S, Dasarathi S, Pahan K. J Clin Cell Immunol; 2017 Feb 01; 8(1):. PubMed ID: 28367355 [Abstract] [Full Text] [Related]
9. Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis. Mondal S, Roy A, Pahan K. J Immunol; 2009 Apr 15; 182(8):5013-23. PubMed ID: 19342681 [Abstract] [Full Text] [Related]
13. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice. Bing SJ, Ha D, Hwang I, Park E, Ahn G, Song JY, Jee Y. Am J Chin Med; 2016 Apr 15; 44(6):1099-1110. PubMed ID: 27627913 [Abstract] [Full Text] [Related]
14. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Am J Pathol; 1999 Oct 15; 155(4):1147-61. PubMed ID: 10514398 [Abstract] [Full Text] [Related]
15. Correction to: Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy. Mondal S, Rangasamy SB, Ghosh S, Watson RL, Pahan K. Neurochem Res; 2018 May 15; 43(5):1136-1139. PubMed ID: 29611013 [Abstract] [Full Text] [Related]
16. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS). Schorlemmer HU, Seiler FR. Drugs Exp Clin Res; 1991 May 15; 17(10-11):461-9. PubMed ID: 1841035 [Abstract] [Full Text] [Related]
17. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor. Hammer LA, Zagon IS, McLaughlin PJ. Brain Res Bull; 2013 Sep 15; 98():122-31. PubMed ID: 23973432 [Abstract] [Full Text] [Related]